Tissue Engineering

Tissue engineering is the attempt to build living tissue—skin, cartilage, bone, blood vessels, even whole organs—by combining cells, materials, and chemical signals in the laboratory so that the body can repair or replace what disease and injury have destroyed.

8 frameworks, from 1975 to today · Biomedical Engineering · Engineering

still a working view ended · each leads to its entry below

Overview

Tissue engineering is the attempt to build living tissue—skin, cartilage, bone, blood vessels, even whole organs—by combining cells, materials, and chemical signals in the laboratory so that the body can repair or replace what disease and injury have destroyed1. Its practitioners are engineers, biologists, surgeons, and materials scientists who share one conviction: that a damaged tissue should not merely be patched with inert material but given the living components and the structural cues it needs to rebuild itself. What is at stake is the shortage of donor organs, the failure of permanent implants, and the possibility of making replacement tissue on demand rather than waiting for a donor.

Skin, the First Engineered Tissue

The field's practical origins lie in the burn ward. In the late 1970s and early 1980s, surgeons and cell biologists worked out how to grow a patient's own skin cells in culture and return them to the wound. A landmark demonstration came from Howard Green and colleagues at Harvard, who in the late 1970s showed that human epidermal cells could be expanded enormously in culture—a small biopsy yielding sheets large enough to cover a burn patient. By the early 1980s, cultured epidermal sheets were being applied clinically. The problem this solved was severe: patients with massive burns lacked enough intact skin to graft, and donor skin was scarce and rejected. Growing the patient's own cells sidestepped rejection entirely1.

The limitation was equally clear. Epidermal sheets were fragile, had no dermis beneath them, and healed with poor mechanical quality and scarring. This pushed researchers toward bilayer constructs and toward the idea that a scaffold—a temporary structural framework—was needed to give cells a three-dimensional home.

The Scaffold Paradigm

The idea that crystallized in the 1980s and 1990s was that tissue could be engineered by seeding cells onto a porous, biodegradable scaffold that mimicked the extracellular matrix—the mesh of proteins and sugars that surrounds cells in the body and gives tissue its shape. The scaffold would provide mechanical support and a template, the cells would populate it, and the material would degrade as new tissue formed1. Robert Langer and Joseph Vacanti gave this vision its most influential statement in a 1993 paper in Science, framing tissue engineering as an interdisciplinary field drawing on materials science, cell biology, and surgery. The paper became a touchstone, and the scaffold paradigm it described dominated the field for the next two decades.

The materials problem was substantial. A scaffold had to be biocompatible, degrade at a rate matched to tissue formation, and be processable into complex shapes. Early work used synthetic polyesters such as polyglycolic acid and polylactic acid, already familiar from resorbable sutures, alongside natural materials like collagen. Fabrication methods—salt leaching to create pores, fiber spinning, gas foaming—were borrowed and adapted from polymer engineering. A concrete early success was a collagen-based skin substitute combining a porous collagen matrix with cultured cells, developed commercially in the 1990s and used for chronic wounds and burns.

The paradigm's central difficulty was that a scaffold seeded with cells in a dish is not a tissue. Cells need blood. Any construct thicker than a fraction of a millimeter starves without a blood supply, because oxygen diffuses only a short distance through living tissue.

Vascularization: The Persistent Barrier

Vascularization—giving engineered tissue a blood vessel network—became and remains one of the field's defining problems1. Approaches multiplied. Some groups seeded scaffolds with endothelial cells, the cells that line blood vessels, hoping they would self-organize into capillaries. Others prefabricated channels within scaffolds, or used growth factors such as vascular endothelial growth factor (VEGF) to coax the host's own vessels to invade the implant. Each approach worked in part and failed in part: capillaries formed but often leaked or regressed, and thick constructs still died in their interiors. The problem is not solved today; it is the reason engineered tissue has succeeded most where tissue is thin or where the host's blood supply can reach it easily.

Stem Cells and the Signaling Turn

A second transformation came from stem cell biology. Embryonic stem cells, first isolated from human embryos in 1998, and induced pluripotent stem cells—adult cells reprogrammed back to an embryonic-like state, reported by Shinya Yamanaka's group in 2006—offered a source of cells that could become any tissue type23. This changed the field's ambition: instead of harvesting a patient's mature cells, one might direct a stem cell down a chosen developmental path.

The key insight was that development itself is a set of chemical instructions. Developmental biologists had mapped the signaling pathways—the molecular conversations—that tell an embryo what to build where. Tissue engineers began to borrow these instructions, adding specific growth factors and small molecules in timed sequences to steer stem cells toward cartilage, heart muscle, or nerve. The field began to think of itself less as materials science with cells attached and more as developmental signaling engineering: reproducing, in a dish, the sequence of cues that builds a tissue in the embryo.

Decellularized Matrices

A parallel strand asked whether the best scaffold might be a real organ with its cells removed. In decellularization, a donor organ or tissue is treated with detergents and enzymes to strip away its cells, leaving behind the extracellular matrix—an intact, organ-shaped framework of collagen and other proteins, complete with its native blood vessel channels. The idea gained prominence in the mid-2000s, when researchers reported repopulating decellularized hearts and livers with new cells. The appeal was that the matrix already had the architecture and the vascular plumbing that synthetic scaffolds struggled to reproduce. The obstacles were equally real: achieving complete decellularization without damaging the matrix, and getting cells to repopulate a dense organ thoroughly enough to function.

Organoids: Tissue That Builds Itself

The most striking shift of the 2000s and 2010s was the recognition that cells, given the right conditions, can build tissue themselves. In 2009, Hans Clevers's group showed that a single intestinal stem cell could be grown into a miniature, self-organizing structure—an organoid—containing the folded architecture of the gut lining. Similar methods produced miniature kidneys, brains, and other tissues. Organoids inverted the scaffold paradigm: rather than imposing structure from outside, researchers provided a permissive environment and let the cells' own developmental programs do the organizing. Organoids became both a research tool for studying disease and development and a candidate source of tissue for therapy, though they remain small and lack a blood supply.

Bioprinting

The most recent major method is bioprinting: depositing living cells and materials layer by layer, under computer control, to build three-dimensional tissue with defined architecture. Early work in the 2000s adapted inkjet and extrusion printing to biological "inks"—hydrogels carrying cells. The promise is precise placement: putting different cell types exactly where they belong, and printing channels that could become blood vessels. The field has produced printed skin, cartilage, and small tissue constructs, and printed organ models for study. The same vascularization barrier limits it: printed tissue thick enough to matter still needs a blood supply1.

Cell Therapy and the Clinical Record

Alongside the scaffold tradition ran a simpler idea: inject or infuse cells and let the body do the rest. Cell-based therapy—delivering stem cells or progenitor cells to a damaged heart, cartilage, or wound—was pursued intensively from the 2000s. The clinical record has been mixed and instructive. Some therapies reached patients, notably cultured skin and cartilage repair techniques; many early trials reported modest or inconsistent benefits, and the field learned to demand rigorous controls. This has pushed the field toward better-defined cells and combination approaches that pair cells with materials and signals.

Where the Field Stands

Today the main approaches coexist rather than compete. Scaffold-based engineering remains the workhorse, now with smarter materials that release signals and match tissue mechanics. Decellularized matrices supply native architecture1. Stem cell and developmental signaling methods supply the cells and the instructions1. Organoids and bioprinting supply self-organization and precision placement4. Vascularization remains the central unsolved problem, and the field's clinical successes—skin, cartilage, some bladder and airway tissue—are largely in thin or well-perfused tissues. The open questions are how to build thick, vascularized tissue that survives; how to make stem cell derivatives reliably and safely; and how to move constructs from the laboratory into regulated, scalable products. The field's history is a record of learning that building living tissue means respecting biology's own rules—and that the body, given the right cues, is often the best engineer.

References

  1. Tissue engineering (introduction, Genetic classifications of cells, Scaffolds, Overview, Assembly methods, Modern era (20th and 21st centuries), Materials, Stem cells), Wikipedia
  2. Stem cell (History), Wikipedia
  3. Induced pluripotent stem cell, Wikipedia
  4. 3D bioprinting, Wikipedia

The frameworks of Tissue Engineering

Each framework is a way of working the field has used: when it held, and the question it answers.

  1. 1975-1995

    Cultured Cell Sheet Engineering

    How can a patient's own skin cells be grown to cover a wound?

    Fly to its tower in Nousfarer

  2. 1993-Present

    Scaffold-Based Tissue Engineering

    How can a porous framework guide cells to rebuild tissue?

    Fly to its tower in Nousfarer

  3. 1995-Present

    Vascularization Strategies

    How can engineered tissue be given a blood supply?

    Fly to its tower in Nousfarer

  4. 1998-Present

    Stem Cell and Developmental Signaling Engineering

    How can chemical signals steer stem cells into chosen tissues?

    Fly to its tower in Nousfarer

  5. 2000-Present

    Cell Therapy

    Can injected cells alone repair damaged tissue?

    Fly to its tower in Nousfarer

  6. 2003-Present

    3D bioprinting

    How can cells and materials be printed into living tissue?

    Fly to its tower in Nousfarer

  7. 2005-Present

    Decellularization

    Can a real organ's matrix serve as a scaffold for new cells?

    Fly to its tower in Nousfarer

  8. 2009-Present

    Organoid

    Can cells build miniature tissues on their own?

    Fly to its tower in Nousfarer

How the ideas connect

Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.

Cultured Cell Sheet EngineeringScaffold-Based Tissue EngineeringVascularization StrategiesStem Cell and Developmental Signaling…Cell Therapy3D bioprintingDecellularizationOrganoid

Beyond the field

Where Tissue Engineering's ideas came from in other fields, and what they led to there: the strongest 12 of 16 links.

A city in Nousfarer: a red-carpeted stair climbing terraces to a crowned tower on an acropolis, more towers round it, forest and snowy mountains beyond.
A city in Nousfarer, the game played in the browser.

Tissue Engineering is a planet in Nousfarer

Its city has a tower for each of these 8 frameworks. Land, walk in, and climb one concept at a time.

Land on Tissue Engineering

Related fields

Fields its ideas are linked to

More in Biomedical Engineering

See where Tissue Engineering sits on the Map of Human Knowledge